Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction Chemotherapy vs Concurrent Chemoradiotherapy in Hypopharyngeal Carcinoma
NCT03558035Phase 2Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Sep 2014
- Primary completion
- Feb 2021
- Modality
- Nanoparticles, Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection, Cisplatin micelle injection (HA132), fluorouracil in hypopharyngeal carcinoma (HPC), sponsored by Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
Paclitaxel Micelles for InjectionCisplatin micelle injection (HA132)fluorouracil
03
Conditions
hypopharyngeal carcinoma (HPC)
Beyond the preview
Go deeper on NCT03558035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03558035.